DNA - Ginkgo Bioworks Holdings - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

DNA is currently covered by 6 analysts with an average price target of $58.41. This is a potential upside of $49.05 (524.04%) from yesterday's end of day stock price of $9.36.

Ginkgo Bioworks Holdings's activity chart (see below) currently has 11 price targets and 24 ratings on display. The stock rating distribution of DNA is 25% BUY, 50% SELL and 25% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 43.33% with an average time for these price targets to be met of 52.67 days.

Highest price target for DNA is $40, Lowest price target is $7, average price target is $58.41.

Most recent stock forecast was given by MARK MASSARO from BTIG on 23-Aug-2024.

Currently out of the existing stock ratings of DNA, 3 are a BUY (25%), 6 are a SELL (50%), 3 are a HOLD (25%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Sell

$7

$-3.08 (-30.56%)

$8

4 months 2 days ago
(23-Aug-2024)

2/5 (40%)

$-1.15 (-14.11%)

31

Sell

$12

$1.92 (19.05%)

$44

5 months 16 days ago
(09-Jul-2024)

3/3 (100%)

$-0.34 (-2.76%)

95

Hold

$40

$29.92 (296.83%)

$200

7 months 10 days ago
(15-May-2024)

0/2 (0%)

$6.44 (19.19%)

Buy

9 months 24 days ago
(01-Mar-2024)

0/1 (0%)

$310 (182.35%)

Hold

$100

$89.92 (892.06%)

1 years 1 months 11 days ago
(14-Nov-2023)

1/2 (50%)

$42.4 (73.61%)

6

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is DNA (Ginkgo Bioworks Holdings) average time for price targets to be met?

On average it took 52.67 days on average for the stock forecasts to be realized with a an average price target met ratio 43.33

Which analyst has the current highest performing score on DNA (Ginkgo Bioworks Holdings) with a proven track record?

MATTHEW SYKES

Which analyst has the current lower performing score on DNA (Ginkgo Bioworks Holdings) with a proven track record?

TEJAS SAVANT

Which analyst has the most public recommendations on DNA (Ginkgo Bioworks Holdings)?

Matthew Sykes works at GOLDMAN SACHS and has 9 price targets and 5 ratings on DNA

Which analyst is the currently most bullish on DNA (Ginkgo Bioworks Holdings)?

Laurence Alexander with highest potential upside - $163.92

Which analyst is the currently most reserved on DNA (Ginkgo Bioworks Holdings)?

Derik De Bruin with lowest potential downside - -$3.69

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?